XBIOTECH INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
XBIOTECH INC. (XBIT) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 4.61 million shares for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2022-11-09
- XBIOTECH INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2016-03-31 was 5.08M shares, a 0.72% increase year-over-year.
- XBIOTECH INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2015-03-31 was 5.05M shares, a 35.28% increase year-over-year.
- XBIOTECH INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2014-03-31 was 3.73M shares.
- XBIOTECH INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2021 was 4.66M shares, a 12.59% decline from fiscal 2020.
- XBIOTECH INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2020 was 5.33M shares, a 23.52% decline from fiscal 2019.
- XBIOTECH INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2019 was 6.97M shares, a 25.84% increase from fiscal 2018.
- XBIOTECH INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2018 was 5.54M shares, a 4.37% increase from fiscal 2017.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2022-09-30 | 4.61M shares 10-Q · filed 2022-11-09 | |||
| 2022-06-30 | 4.71M shares 10-Q · filed 2022-08-10 | |||
| 2021-12-31 | 4.66M shares 10-K · filed 2022-03-15 | |||
| 2021-09-30 | 4.28M shares 10-Q · filed 2022-11-09 | |||
| 2021-06-30 | 4.63M shares 10-Q · filed 2022-08-10 | |||
| 2020-12-31 | 5.33M shares 10-K · filed 2022-03-15 | |||
| 2019-12-31 | 6.97M shares 10-K · filed 2022-03-15 | |||
| 2018-12-31 | 5.54M shares 10-K · filed 2021-03-16 | |||
| 2017-12-31 | 5.30M shares 10-K · filed 2020-03-16 | |||
| 2016-12-31 | 5.19M shares 10-K/A · filed 2019-03-15 | |||
| 2016-09-30 | 5.22M shares 10-Q · filed 2016-11-14 | |||
| 2016-06-30 | 5.28M shares 10-Q · filed 2016-08-12 | |||
| 2016-03-31 | 5.08M shares 10-Q · filed 2016-05-13 | |||
| 2015-12-31 | 4.79M shares 10-K · filed 2018-03-16 | |||
| 2015-09-30 | 5.00M shares 10-Q · filed 2016-11-14 | |||
| 2015-06-30 | 4.95M shares 10-Q · filed 2016-08-12 | |||
| 2015-03-31 | 5.05M shares 10-Q · filed 2016-05-13 | |||
| 2014-12-31 | 5.38M shares 10-K · filed 2017-03-16 | |||
| 2014-09-30 | 4.48M shares 10-Q · filed 2015-11-13 | |||
| 2014-06-30 | 4.24M shares 10-Q · filed 2015-08-14 | |||
| 2014-03-31 | 3.73M shares 10-Q · filed 2015-06-18 | |||
| 2013-12-31 | 4.60M shares 10-K · filed 2016-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |